Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

W. J. Sandborn, E. V. Loftus

Research output: Contribution to journalComment/debate

61 Scopus citations
Original languageEnglish (US)
Pages (from-to)780-782
Number of pages3
JournalGut
Volume53
Issue number6
DOIs
StatePublished - Jun 1 2004

ASJC Scopus subject areas

  • Gastroenterology

Cite this